List of works by Norman Stockbridge

2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials.

scientific article published in February 2018

2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials.

scientific article published in March 2018

Agents with vasodilator properties in acute heart failure: how to design successful trials

scientific article

Antithrombotic drug development for atrial fibrillation: proceedings, Washington, DC, July 25-27, 2005.

scientific article published on May 2008

Cardiovascular drug development: is it dead or just hibernating?

scientific article published on April 2015

Clinical and research issues regarding chronic advanced coronary artery disease part II: Trial design, outcomes, and regulatory issues

scientific article published on 31 January 2008

Clinical outcome endpoints in heart failure trials: a European Society of Cardiology Heart Failure Association consensus document

scientific article published on 19 June 2013

Design of a "Lean" Case Report Form for Heart Failure Therapeutic Development

scientific article published on 07 August 2019

Developing therapies for heart failure with preserved ejection fraction: current state and future directions

scientific article

Exploring New Endpoints for Patients With Heart Failure With Preserved Ejection Fraction

scientific article

FDA in the 21st Century: Focus on Tobacco Policies and Heart Failure Prevention

scientific article published on 01 February 2017

Heart Failure End Points in Cardiovascular Outcome Trials of Sodium Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes Mellitus: A Critical Evaluation of Clinical and Regulatory Issues

scientific article published on 16 December 2019

Heart Failure With Preserved Ejection Fraction Expert Panel Report: Current Controversies and Implications for Clinical Trials

scientific article published on 01 August 2018

Implications of geographical variation on clinical outcomes of cardiovascular trials

scientific article published on 03 August 2012

Improving Heart Failure Therapeutics Development in the United States: The Heart Failure Collaboratory

scientific article

Improving cardiovascular clinical trials conduct in the United States: recommendation from clinicians, researchers, sponsors, and regulators

scientific article

JACC: Heart Failure Series: FDA in the 21st Century: Focus on Nutrition and Heart Failure Prevention

scientific article published on March 2017

Large streamlined trials in cardiovascular disease

scientific article published on 2 January 2014

New approaches to hyperkalemia in patients with indications for renin angiotensin aldosterone inhibitors: Considerations for trial design and regulatory approval

scientific article published on 19 April 2016

Phase III clinical trial end points in acute heart failure syndromes: A virtual roundtable with the acute heart failure syndromes international working group

article

Preventing tomorrow's sudden cardiac death today: part II: Translating sudden cardiac death risk assessment strategies into practice and policy

scientific article published in June 2007

Reassessing Phase II Heart Failure Clinical Trials: Consensus Recommendations

scientific article published on April 2017

Resourcing Drug Development Commensurate With its Public Health Importance: The Road Ahead.

scientific article published on 29 August 2016

Site selection for heart failure clinical trials in the USA.

scientific article published in July 2015

Site selection in global clinical trials in patients hospitalized for heart failure: perceived problems and potential solutions

scientific article

Stroke prevention in atrial fibrillation: Closing the gap

scientific article published on 25 October 2018

Technology-Enabled Clinical Trials: Transforming Medical Evidence Generation

scientific article published on 21 October 2019

The FDA in the 21st Century: How Is the FDA Responding to the New World? A Focus on Cardiovascular Drug Development

scientific article published on January 2017

The FDA in the 21st Century: How Is the FDA Responding to the New World? A Focus on Heart Failure Devices.

scientific article published in December 2016

Treatment of HF in an Era of Multiple Therapies: Statement From the HF Collaboratory

scientific article published on 09 December 2020